Risque non accru d'infection avec hospitalisation sous thérapies ciblées versus méthotrexate chez les patients âgés atteints de polyarthrite rhumatoïde : une étude de cohorte rétrospective
Arthritis Res Ther. 2022 doi: 10.1186/s13075-022-02807-9
Retrospective, longitudinal, population-based study shows that despite an overall higher incidence of hospitalised infection (HI) in both elderly and older elderly patients compared to young patients, the risks of HI in patients exposed to targeted therapy versus MTX is not significantly increased.